Nanoform Finland Oyj (HEL:NANOFH)

Market Cap	109.66M
Revenue (ttm)	3.95M
Net Income (ttm)	-22.54M
Shares Out	85.67M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,255
Average Volume	264,637
Open	1.282
Previous Close	1.280
Day's Range	1.282 - 1.290
52-Week Range	0.724 - 1.820
Beta	0.58
RSI	78.85
Earnings Date	Nov 12, 2025

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 181
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2024, Nanoform Finland Oyj's revenue was 3.66 million, an increase of 42.70% compared to the previous year's 2.57 million. Losses were -23.43 million, 12.9% more than in 2023.